Recent Health Care Deals, week ending 02.03.2017
AcquirerTargetPrice Piramal Critical Care Inc. Mallinckrodt's intrathecal therapy business$203 million Incyte CorporationLicense to CB-1158$45 million CareTrust REIT, Inc.2 memory care companies$26.1 million Diplomat Pharmacy, Inc. Affinity Biotech Inc. $16 million Regional hospital systemsWingate at Melrose$3.6... Read More »Recent Health Care Deals, week ending 01.27.2017
AcquirerTargetPrice Johnson & JohnsonActelion Ltd. $30.1 billion McKesson CorporationCoverMyMeds$1.4 billion Celgene CorporationDelinia, Inc. $300 million Generex Biotechnology Corp.Emmaus Life Sciences, Inc. $225 million Intrexon CorporationGenVec Inc. $15.9... Read More »Q4:16 Healthcare Deals Continue Downward Drift
Deal volume has trended downward in 2016, after spiking in the second quarter with a total of 421 deals. The third quarter logged 375 deals, and the fourth quarter’s total slipped 2%, to 366 transactions. These are not major shifts, and every quarter since Q1:14 has reported totals of greater than 350 transactions. We may be witnessing the beginning of a real downward trend, if enough investors are spooked by the Trump administration and Congress’s efforts to repeal and replace the Affordable Care Act. No replacement plan has been approved as of this writing a week after the inauguration of Donald Trump, although some senators have put forward their own plans to be debated. Healthcare... Read More »Recent Health Care Deals, week ending 01.20.2017
AcquirerTargetPrice Eli Lilly and CompanyCoLucid Pharmaceuticals$960 million Auxilio, Inc. CynergisTek$26.8 million Bain Capital Private EquityPSA HealthcareN/A InTandem Capital Partners LLC2 primary care clinicsN/A HonorHealth12 oncology clinics in... Read More »Recent Health Care Deals, week ending 01.13.2017
AcquirerTargetPrice Takeda PharmaceuticalsAriad Pharmaceuticals$4.66 billion OptumSurgical Care Affiliates, Inc.$3.28 billion Sanpower Group Co., Ltd.Dendreon Pharmaceuticals, Inc. $819.9 million Hill-Rom HoldingsMortara Instrument Inc. $330 million Integra LifeSciences Holding Corp.Derma Sciences$204... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
